Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Goldstein

Showing results (51-60 of 136) with videos related to

Pageof 14
Sort By:
Journal of Gastrointestinal Oncology|July 25, 2017
Cost-effectiveness of precision medicine in gastrointestinal stromal tumor and gastric adenocarcinomaSimon B Zeichner, Daniel A Goldstein, Christine Kohn, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 7, 2022
Health Disparities in Prostate Cancer and Approaches to Advance Equitable CareCyrus Washington, Daniel A Goldstein, Assaf Moore, et al.
Journal of Toxicology. Clinical Toxicology|January 1, 2003
An analysis of glyphosate data from the California Environmental Protection Agency Pesticide Illness Surveillance ProgramDaniel A Goldstein, John F Acquavella, Rhonda M Mannion, et al.
Clinical Pharmacology and Therapeutics|December 2, 2021
Dose Optimization of Pembrolizumab: Less May Be MoreMark J Ratain, Cody J Peer, William D Figg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Reply to A. Messori et al, R. Bordonaro et al, and G. Fasola et alDaniel A Goldstein, Bassel F El-Rayes, Qiushi Chen, et al.
BMJ Oncology|January 31, 2025
Pharmacological class effects of anticancer drugs: opportunities for decreasing healthcare spendingDaniel A Goldstein, Leonard B Saltz, Gregory R Pond, et al.
International Journal of Clinical and Health Psychology : IJCHP|September 14, 2019
Treatment impact on recidivism of family only vs. generally violent partner violence perpetratorsArthur L Cantos, David S Kosson, Daniel A Goldstein, et al.
Frontiers in Pharmacology|November 5, 2021
Factors Associated With Off-Label Oncology Prescriptions: The Role of Cost and Financing in a Universal Healthcare SystemNoa Gordon, Daniel A Goldstein, Boaz Tadmor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2023
Evaluating Trials of Adjuvant Therapy: Is There Benefit for People With Resected Renal Cancer?Ian F Tannock, Daniel A Goldstein, Jonathan Ofer, et al.
Journal of the American Pharmacists Association : Japha|July 19, 2018
A real-world analysis of cancer drug wastage due to oversized vialsOri Liran, Judit Prus, Noa Gordon, et al.
Pageof 14

Showing results (51-60 of 136) with videos related to

Sort By:
Pageof 14
Journal of Gastrointestinal Oncology|July 25, 2017
Cost-effectiveness of precision medicine in gastrointestinal stromal tumor and gastric adenocarcinomaSimon B Zeichner, Daniel A Goldstein, Christine Kohn, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 7, 2022
Health Disparities in Prostate Cancer and Approaches to Advance Equitable CareCyrus Washington, Daniel A Goldstein, Assaf Moore, et al.
Journal of Toxicology. Clinical Toxicology|January 1, 2003
An analysis of glyphosate data from the California Environmental Protection Agency Pesticide Illness Surveillance ProgramDaniel A Goldstein, John F Acquavella, Rhonda M Mannion, et al.
Clinical Pharmacology and Therapeutics|December 2, 2021
Dose Optimization of Pembrolizumab: Less May Be MoreMark J Ratain, Cody J Peer, William D Figg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Reply to A. Messori et al, R. Bordonaro et al, and G. Fasola et alDaniel A Goldstein, Bassel F El-Rayes, Qiushi Chen, et al.
BMJ Oncology|January 31, 2025
Pharmacological class effects of anticancer drugs: opportunities for decreasing healthcare spendingDaniel A Goldstein, Leonard B Saltz, Gregory R Pond, et al.
International Journal of Clinical and Health Psychology : IJCHP|September 14, 2019
Treatment impact on recidivism of family only vs. generally violent partner violence perpetratorsArthur L Cantos, David S Kosson, Daniel A Goldstein, et al.
Frontiers in Pharmacology|November 5, 2021
Factors Associated With Off-Label Oncology Prescriptions: The Role of Cost and Financing in a Universal Healthcare SystemNoa Gordon, Daniel A Goldstein, Boaz Tadmor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2023
Evaluating Trials of Adjuvant Therapy: Is There Benefit for People With Resected Renal Cancer?Ian F Tannock, Daniel A Goldstein, Jonathan Ofer, et al.
Journal of the American Pharmacists Association : Japha|July 19, 2018
A real-world analysis of cancer drug wastage due to oversized vialsOri Liran, Judit Prus, Noa Gordon, et al.
Pageof 14